4 completed, 3 recruiting, 1 active not recruiting, 1 terminated. 6 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow carboxypeptidase M: new trials by email Literature Review of carboxypeptidase M trials Research Report on carboxypeptidase M
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endometriosis and Migraine Thermal stimuli, Pressure stimuli, Pain ratings - Migraine, Endometriosis | Recruiting | Washington University School of Medicine | 120 | 2025-02-12 | 2026-07-13 | |
| Differential Assessment of Hypertonia Continuous passive motion device (CPM) of ankle - fast, Continuous passive motion device (CPM) of ankle - slow - SCI - Spinal Cord Injury, PD - Parkinson's Disease | Not applicable | Recruiting | Chang Gung University | 45 | 2024-10-09 | 2024-10-15 |
| Migraine in Adolescents MRI, Thermal Stimuli, Pressure stimuli - Migraine | Not applicable | Recruiting | Washington University School of Medicine | 250 | 2023-06-01 | 2026-07-13 |
| Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine Thermal stimuli, Pressure stimuli, Pain ratings - Migraine | Not applicable | Active not recruiting | Washington University School of Medicine | 100 | 2023-01-10 | 2026-07-13 |
| Phenotyping of Chronic Pain in Diffused Systemic Scleroderma QST, CPM and Paisudoscan - Scleroderma, Systemic, Scleroderma, Diffuse | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 100 | 2022-10-19 | 2024-12-04 |
| Pain Sensitivity During Puberty Thermal Sensory Analyzer, Pressure Stimuli, Mechanical Stimuli - Pain | Not applicable | Completed | Washington University School of Medicine | 36 | 2022-09-20 | 2026-01-09 |
| Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Doxorubicin, Trastuzumab, Cyclophosphamide - Breast Neoplasms | Phase 2 | Terminated | Washington University School of Medicine | 7 | 2013-12-19 | 2022-11-01 |
| Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens Standard Dose Dense Doxorubucin and Cyclophosphamide, Standard Doxorubucin and Cyclophosphamide, Standard Docetaxel, Carboplatin, and Herceptin - Breast Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 35 | 2008-04-01 | 2019-01-22 |
| Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma filgrastim, rituximab, carboplatin - Lymphoma | Phase 2 | Completed | Eastern Cooperative Oncology Group | 100 | 2006-09-26 | 2023-06-29 |
Migraine Disorders (3) · Pain (3) · Breast Neoplasms (2) · Endometriosis (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Muscle Rigidity (1) · Muscle Spasticity (1) · Parkinson Disease (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Spinal Cord Injuries (1)
Washington University School of Medicine (5) · Assistance Publique - Hôpitaux de Paris (1) · Chang Gung University (1) · Eastern Cooperative Oncology Group (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (7) · France (1) · Taiwan (1)
Hadas Nahman-Averbuch, PhD (4) · Amit Shah, M.D. (1) · Lode J. Swinnen, MD (1) · Rebecca Aft, M.D., Ph.D. (1) · Richard Zellars, M.D. (1)
R01NS129742 (1), R01NS134986 (1), U10CA021115 (1)